As a news service reported the British newspaper “Daily Telegraph” pre-test preparation “Immutsin” showed that the new tool is able to strengthen the human immune system and help fight the disease. Cancer cells are usually not recognized by the immune system as a threat.
The creators of the drug say that it can be an effective means of combating small tumors and common forms of the disease such as breast cancer and prostate cancer. It may also be useful for patients who have undergone therapy, and apprehensive of recurrence. “Immutsin” demonstrated ability to form specific immune response observed in all patients after administration of doses of 2.4.